Your session is about to expire
← Back to Search
Vagus Nerve Stimulation
Vagus Nerve Stimulation + Rehabilitation for Spinal Cord Injury
N/A
Recruiting
Led By Radha Korupolu
Research Sponsored by The University of Texas Health Science Center, Houston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, post-treatment (first day after 6 week inclinic therapy), 30 days, and 90 days follow-up.
Summary
This trial uses a device that sends electrical signals to a nerve in the neck while patients do exercises. It targets adults with partial spinal cord injuries in the neck area who struggle with arm and hand movement. The electrical signals may help improve how the brain and nerves respond to exercise, aiding recovery.
Who is the study for?
This trial is for individuals at least 12 months post-traumatic cervical spinal cord injury (C8 and above), with some upper limb movement, like pinching. They must meet surgical criteria for VNS implantation. Excluded are those with non-traumatic SCI, vocal cord issues, significant brain injuries, prior vagus nerve damage, certain medications affecting neurotransmitters, other complicating conditions or surgeries, medical or mental instability, or pregnancy.
What is being tested?
The study tests the safety and effectiveness of pairing vagus nerve stimulation (VNS) with arm rehabilitation to improve upper extremity function in people with cervical spinal cord injury. Participants will receive either active VNS or a sham procedure alongside their rehabilitation exercises.
What are the potential side effects?
Potential side effects may include discomfort from the VNS device itself and typical risks associated with any surgical implantation procedure. Specific side effects related to VNS can vary but might involve changes in voice tone or involuntary throat sensations.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, post-treatment (first day after 6 week inclinic therapy), 30 days, and 90 days follow-up.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, post-treatment (first day after 6 week inclinic therapy), 30 days, and 90 days follow-up.
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Safety as assessed by number of subjects with post surgical complications
Secondary study objectives
Change in Depression as assessed by the Patient Health Questionnaire (PHQ-8)
Pain
Change in capability of using arms and hands as assessed by the Capabilities of Upper Extremity Questionnaire (CUE-Q)
+4 moreTrial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Treatment groupExperimental Treatment2 Interventions
Participants in the treatment group will receive 18 goal-directed upper extremity rehabilitation therapy sessions with paired VNS over six weeks. Followed by 90 days home exercise program.
Group II: Control GroupPlacebo Group2 Interventions
Participants in the control group will receive 18 goal-directed upper extremity rehabilitation therapy sessions with sham VNS over six weeks. Followed by 90 days home exercise program.
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for spinal cord injury (SCI) include neuromodulation techniques such as Vagus Nerve Stimulation (VNS) and Transcutaneous Electrical Nerve Stimulation (TENS). VNS works by delivering electrical impulses to the vagus nerve, which can enhance neuroplasticity and improve rehabilitation outcomes by modulating the central nervous system's response to injury.
TENS provides symptomatic relief by altering pain perception through continuous electrical impulses delivered via surface electrodes. These treatments are crucial for SCI patients as they can potentially improve motor function, reduce pain, and enhance overall quality of life by leveraging the body's own neural pathways to promote recovery and adaptation.
Efficacy of pulsed low-intensity electric neuromuscular stimulation in reducing pain and disability in patients with myofascial syndrome.
Efficacy of pulsed low-intensity electric neuromuscular stimulation in reducing pain and disability in patients with myofascial syndrome.
Find a Location
Who is running the clinical trial?
The University of Texas Health Science Center, HoustonLead Sponsor
957 Previous Clinical Trials
347,852 Total Patients Enrolled
MicroTransponder Inc.Industry Sponsor
7 Previous Clinical Trials
1,336 Total Patients Enrolled
Radha KorupoluPrincipal InvestigatorThe University of Texas Health Science Center, Houston
1 Previous Clinical Trials
45 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have a significant brain injury.I am not on medication that affects how VNS works on my brain chemicals.It has been over a year since my spinal cord injury.My spinal cord injury was not caused by a physical injury.I don't have health issues that would make surgery risky.I have had neck surgery on the left side and have excessive scar tissue, as confirmed by a neurosurgeon.I have trouble swallowing or often choke while eating.I have been diagnosed with vocal cord paralysis through a laryngoscopy.I am eligible for a VNS implant surgery as per my medical team.I have a spinal cord injury in my neck that is not complete.It has been over a year since my spinal cord injury.I can move my fingers enough to pinch.I can move my fingers enough to pinch.
Research Study Groups:
This trial has the following groups:- Group 1: Treatment group
- Group 2: Control Group
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.